Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genzyme Tissue Repair - GZTR -- Ignore unavailable to you. Want to Upgrade?

To: BWAC who wrote (219)	7/21/1999 3:56:00 PM
From: KLH	Read Replies (1) \| Respond to of 405

BW, although I have been leery about the insider purchases(motives), it would seem that if their purchases are for investment appreciation, they must have a time frame in mind. I doubt they would be buying if GZTR was going nowhere in the next 12 months. It would seem that management's bottom line targets are on schedule and these insider purchases are all we have to go on that price appreciation is expected. They don't seem to be buying the other orphans vis a vis GZTR. Karl